Sudarshan Chemical Industries Ltd
Sudarshan Chemical Industries Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Legacy Sudarshan business: Expected to return to its long-term growth rate of around 10-11% CAGR, with growth resuming from Q4 FY '26 onwards. Legacy Sudarshan business is expected to return to a long-term sustainable growth rate of around 10%-11% CAGR (Rajesh Rathi, Page 13). - The company anticipates gradual improvement in operating performance with cost optimization and working capital initiatives, resulting in building up to ~10% margin or close to EUR 90-100 million EBITDA over the next few years (Page 14). - Synergies and cost savings pipeline is strong, with a 3-4 year target to deliver EUR 90-100 million EBITDA largely through cost reduction and normalized sales (Page 9). - The impact of inventory reduction (EUR 30-40 million reduction) will positively affect cash flow and net debt but may temporarily suppress reported EBITDA by EUR 9-12 million over the next 3 quarters, normalizing thereafter (Page 6-7). - Confident of improved profitability from Q4 FY26 onwards supported by customer restocking and demand recovery (Page 14).
From Sudarshan Chemical Industries Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Legacy Sudarshan business: Expected to return to its long-term growth rate of around 10-11% CAGR, with growth resuming from Q4 FY '26 onwards.
- Acquired business (Heubach): Anticipated sales growth after inventory destocking phase; production volumes will initially lag sales, normalizing post-Q2 FY '27.
- Demand Improvement: Customers showed subdued demand in first 7-8 months but demand improved substantially after November, indicating recovery.
- New product investments in legacy business are performing well, with growing demand and potential margin improvements.
- Overall revenue growth is expected to be gradual and back-ended with a ramp-up as cost optimization and synergies take effect.
- Industry-wide demand challenges are seen as temporary; normal buying patterns expected to resume, supporting volume growth.
Profitability & Margins
See what Sudarshan Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Sudarshan Chemical Industries is focusing on cost reduction and value capture initiatives across operations, procurement, organization, IT, and fixed costs, aiming for EUR 90-100 million EBITDA in 3-4 years.
- The company has inaugurated a Global Capability Center (GCC) on February 4, 2026, aiming to ramp up operations over the next year and improve productivity and response time via digital innovation.
- There is a major initiative to harmonize multiple SAP systems into one by December 2026, enhancing efficiency by simplifying invoicing and process integration.
- Manufacturing footprint rationalization has been largely completed, such as rightsizing Frankfurt operations and transferring production to India; no further major manufacturing changes planned.
- Inventory liquidation is underway to reduce working capital and net debt, with expected positive balance sheet impact but short-term P&L impact due to overhead absorption.
- No explicit mention of new capital expenditure on production capacity expansion, focusing more on operational optimization and integration.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sudarshan Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Management expressed confidence in demand improvement starting January and early February, indicating a positive trend in order inflow.
- Customers had promised to start buying after January, reflecting an uptick in orderbook.
- The subdued demand in prior quarters was mainly due to customer destocking rather than weak end-market orders.
- There is no explicit mention of a large existing order backlog or pending orders; confidence seems based on renewed customer buying behavior and market recovery.
- The company expects demand normalization, supported by customer trust and improved supply chain processes.
- Overall, orderbook visibility appears positive for Q4 FY26 and beyond, driven by genuine demand recovery rather than one-time restocking.
Sudarshan Chemical Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹2.8K Cr, net profit ₹82 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sudarshan Chemical Industries Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q2 FY26 earnings call →
- Q1 FY26 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Clean Science & Technology Ltd (Q3 FY26)
Trade deal with Europe starting in FY '27 to potentially reduce tariffs (5.5%-12%), helping competitiveness against China. Key concall takeaways from Clean…
- Aether Industries Ltd (Q3 FY26)
The company currently services Baker Hughes with 8 products in commercial production (Site 4) generating a run rate of INR 60 crores this quarter. Key concall…
- Kesar Petroproducts Ltd (Q3 FY26)
Export markets constitute about 40% of sales, served through 7-8 distributors across geographies. Key concall takeaways from Kesar Petroprod.'s Q3 FY26…
- Tata Chemicals Ltd (Q3 FY26)
Indian salt capacity expansion of 210 KT per annum with INR 515 crore investment is underway to meet growing demand. Key concall takeaways from Tata…
Frequently Asked Questions
What were Sudarshan Chemical Industries Ltd Q3 FY26 results?
Legacy Sudarshan business: Expected to return to its long-term growth rate of around 10-11% CAGR, with growth resuming from Q4 FY '26 onwards. Legacy Sudarshan business is expected to return to a long-term sustainable growth rate of around 10%-11% CAGR (Rajesh Rathi, Page 13). - The company anticipates gradual improvement in operating performance with cost optimization and working capital initiatives, resulting in building up to ~10% margin or close to EUR 90-100 million EBITDA over the next few years (Page 14). - Synergies and cost savings pipeline is strong, with a 3-4 year target to deliver EUR 90-100 million EBITDA largely through cost reduction and normalized sales (Page 9). - The impact of inventory reduction (EUR 30-40 million reduction) will positively affect cash flow and net debt but may temporarily suppress reported EBITDA by EUR 9-12 million over the next 3 quarters, normalizing thereafter (Page 6-7). - Confident of improved profitability from Q4 FY26 onwards supported by customer restocking and demand recovery (Page 14).
What is Sudarshan Chemical Industries Ltd share price analysis?
Sudarshan Chemical Industries Ltd currently shows a neutral. The stock trades at a P/E of 465.3 with a market cap of ₹8,633 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sudarshan Chemical Industries Ltd planning capital expenditure?
Sudarshan Chemical Industries is focusing on cost reduction and value capture initiatives across operations, procurement, organization, IT, and fixed costs, aiming for EUR 90-100 million EBITDA in 3-4 years.
Keep Sudarshan Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.